The Food and Drug Administration announced this month it would allow genetic testing company 23andMe to resume direct-to-consumer testing for BRCA mutations. One might assume I support the FDA’s decision, since I’m a BRCA2 mutation carrier and an awareness advocate. After all, identifying a BRCA mutation can help a person reduce their risk of ― […]
